MEDICALIP LOGO

MEDICALIP broadcasted on a Chinese news channel - CCTV

Medical IP was introduced by CCTV in China on May 4th, 2019.


(The anchor narrates)
With the continuous development of 3D printing technology in Korea, 3D printing technology for patient treatment and medical operation has been drawing attention in recent years in Korea's medical field.

Surgeons are planning surgery for children with congenital heart disease at a hospital in Seoul, Korea.

The surgical model, the surgeon holding, is based on the current condition of the patient's heart and is made of 1 to 1 by 3D printing. This model can optimize surgical planning by identifying the location of the targeted site and its surrounding environment.

Artificial intelligence image modeling software can convert 2D medical images such as CT and MRI to 3D. Based on the computed data analysis and deep learning AI technology, it is possible to separate problematic areas and peripheral parts in images and develop them into 3D modeling and output to a 3D printer.

3D cell printing technology prints special materials in align with specific parts of a human body. For example, two different materials such as the dermal layer and skin layer, are printed and incubated for two weeks.

In the future, scars and scars can also be transplanted into the skin. Also, the company is using 3D printing technology to improve heart disease.

The size of the 3D printing market in Korea is currently growing 24% annually, and it is estimated that 1 trillion won will be worth about 5.9 billion RMB in 3 years.
 

LATEST NEWS

Article
PressReleasesJun 20 / 2025

MEDICAL IP Showcases ‘MEDIP Box’ at Metaverse Expo 2025

Article
PressReleasesJun 13 / 2025

MEDICAL IP Signs MOU with Africa Future Foundation to Advance Medical Education and Healthcare in Africa

Article
MediaCoverageMay 30 / 2025

DK Medical’s AI-Powered Portable X-ray Heads to Southeast Asia — A First for Korean Smart Imaging Exports

Article
PressReleasesMay 30 / 2025

MEDICAL IP’s “DeepFore” Selected as Cover Story in Journal of Hepatology

1/58

Questions on our public relations?

Ask us now.